Answers are grounded in this paper and cite their sources.
Retrospective study shows distinct metabolic patterns in patients with metabolic syndrome, indicating gender-specific implications.
Background Metabolic syndrome (MetS) is a prevalent condition associated with increased cardiometabolic risk. Despite its clinical significance, the relationships between anthropometric indices and metabolic markers—particularly in a gender-specific context—remain inadequately explored. Methods This retrospective study included 104 patients diagnosed with MetS between 2016 and 2022. Anthropometric indices, including body roundness index (BRI), body mass index (BMI), waist-to-height ratio (WHtR), and weight-to-waist index (WWI), were analyzed for their associations with metabolic markers reflecting insulin resistance and glucose metabolism: fasting blood glucose (FBG), fasting insulin (FIns), and homeostatic model assessment of insulin resistance (HOMA-IR). These markers represent key components of MetS, although other diagnostic elements such as dyslipidemia and hypertension were beyond the scope of this analysis. Gender-specific subgroup analyses were conducted for 57 female and 47 male patients. Results Significant differences in anthropometric and metabolic characteristics were observed between genders. Male patients exhibited higher BMI (40.4 [37.5, 44.2] vs . 37.2 [33.6, 40.3], p = 0.022), waist circumference (128.0 [120.2, 137.5] cm vs . 115.0 [106.0, 120.0] cm, p < 0.001), and FIns levels (22.8 [16.4, 29.5] μIU/mL vs . 17.8 [15.0, 23.4] μIU/mL, p = 0.107). Correlation analyses revealed that BMI and BRI were strongly associated with HOMA-IR and FIns in both genders, with stronger associations observed in males ( e.g ., BMI vs . FIns, r = 0.60, p < 0.001). WHtR was significantly correlated with metabolic markers in males but not in females. WWI showed limited correlations across both genders. Discussion This study highlights distinct gender-specific patterns in the relationships between anthropometric indices and metabolic markers in MetS patients. These findings underscore the importance of tailored strategies in managing MetS, particularly considering gender-based differences in clinical and metabolic profiles.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: